Deal
Danaher Corporation acquires Abcam
December 2023
Full acquisition
Ready
01 Scorecard
The deal at a glance
Private-market deal
Danaher Corporation acquires Abcam
Deal value
approximately $5.7 billion ($24.00 per share cash)
Sector
Life Sciences
Date
December 2023
VectorShift
Made on VectorShift
Danaher Corporation acquired Abcam for approximately $5.7 billion ($24.00 per share cash), a transaction completed in December 2023, structured as all cash (UK scheme).
Abcam operates in Life Sciences, is based in Cambridge, UK.
Advisors not disclosed
No advisory firms have been disclosed for this transaction.